Regarding clinical implications, only two Cochrane SRs provided high-quality evidence relating to use of anti-TNF agents for psoriasis in pediatric patients and use of combined therapy of steroids and vitamin D for scalp psoriasis. This evidence concerns the gene TNF and psoriasis.